Perivascular adipose tissue phenotype and sepsis vascular dysfunction: Differential contribution of NO, ROS and beta 3-adrenergic receptor

Life Sci. 2020 Aug 1:254:117819. doi: 10.1016/j.lfs.2020.117819. Epub 2020 May 19.

Abstract

Aims: Vascular dysfunction plays a key role in sepsis but the role of perivascular adipose tissue (PVAT) in this condition is relatively unknown.

Main methods: Sepsis was induced by cecal ligation and puncture (CLP). The responses of the aorta and superior mesenteric artery to norepinephrine in the presence or absence of PVAT were evaluated. Fluorescent probes measured the production of nitric oxide (NO) and reactive oxygen species (ROS). NO synthases (NOS) and β3-adrenoceptor expression were detected by immunofluorescence and S-nitrosylation by the biotin switch assay.

Key findings: Aorta and superior mesenteric arteries from septic animals with intact PVAT showed a worsened response to the vasoconstrictor compared to vessels without PVAT. PVAT from the aorta (APVAT) produced NO and ROS whereas PVAT from the superior mesenteric artery (MPVAT) produced only ROS. Septic APVAT exhibited a higher density of NOS-1 and NOS-3. S-nitrosylation was found in APVAT. Donor (PVAT obtained from normal or septic rats):Host (normal vessel without PVAT) experiments showed that L-NAME, ODQ and β3-adrenergic receptor antagonist blocked the septic APVAT anti-contractile effect. None of these compounds affected MPVAT; tempol, but not apocynin, blocked its anti-contractile effect.

Significance: PVAT contributes to the anti-contractile effect in the aorta and mesenteric artery of septic rats through different pathways. β3-Adrenergic receptor and NO appear to be key mediators of this effect in APVAT, but not in MPVAT where ROS seem to be a relevant mediator. Therefore, PVAT is a relevant player of sepsis vascular dysfunction.

Keywords: Nitric oxide; Perivascular adipose tissue; Reactive oxygen species; Sepsis; Vascular dysfunction.

MeSH terms

  • Acetophenones / pharmacology
  • Adipose Tissue / metabolism
  • Adrenergic beta-3 Receptor Agonists / pharmacology
  • Animals
  • Aorta / metabolism*
  • Cyclic N-Oxides / pharmacology
  • Female
  • Mesenteric Arteries / metabolism*
  • NG-Nitroarginine Methyl Ester / pharmacology
  • Nitric Oxide / metabolism*
  • Nitric Oxide Synthase / metabolism
  • Norepinephrine / pharmacology
  • Oxadiazoles / pharmacology
  • Phenotype
  • Quinoxalines / pharmacology
  • Rats
  • Reactive Oxygen Species / metabolism*
  • Receptors, Adrenergic, beta-3 / biosynthesis
  • Receptors, Adrenergic, beta-3 / physiology*
  • Sepsis / physiopathology*
  • Spin Labels
  • Vasoconstriction / drug effects
  • Vasoconstriction / physiology

Substances

  • 1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one
  • Acetophenones
  • Adrenergic beta-3 Receptor Agonists
  • Cyclic N-Oxides
  • Oxadiazoles
  • Quinoxalines
  • Reactive Oxygen Species
  • Receptors, Adrenergic, beta-3
  • Spin Labels
  • Nitric Oxide
  • acetovanillone
  • Nitric Oxide Synthase
  • tempol
  • NG-Nitroarginine Methyl Ester
  • Norepinephrine